Medicine and Dentistry
Patient
100%
Colorectal Cancer
64%
Body Mass Index
54%
Obesity
52%
Therapeutic Procedure
52%
Inpatient
50%
Malignant Neoplasm
49%
Cancer Risk
49%
Neoplasm
45%
Survival
42%
Association
38%
Surgery
36%
Rectum Cancer
30%
Systematic Review
27%
Chemoradiotherapy
27%
Follow up
24%
Meta-Analysis
24%
Cytoreductive Surgery
21%
Biological Marker
20%
Endometrial Cancer
19%
Mortality
19%
Anal Cancer
19%
Pseudomyxoma Peritonei
18%
Age
18%
Diseases
17%
Woman
17%
Adult
16%
Serum
15%
Diabetes
15%
Hazard Ratio
14%
Analysis
14%
Enalapril Maleate
14%
Somatomedin C
13%
Overall Survival
13%
Chemotherapy
13%
Screening
13%
Hyperthermic Intraperitoneal Chemotherapy
12%
Health
12%
Colon Cancer
11%
Cohort Analysis
11%
Acromegaly
11%
Adenoma
11%
Maturity Onset Diabetes of the Young
10%
Cancer Incidence
10%
Development
10%
Growth Hormone
10%
Squamous Cell Carcinoma
9%
Programmed Cell Death
9%
Breast Cancer
9%
Colonoscopy
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
43%
Colorectal Cancer
26%
Survival
25%
Neoplasm
22%
Obesity
21%
Cancer Risk
21%
Biological Marker
17%
Chemoradiation Therapy
16%
Rectum Cancer
14%
Enalapril Maleate
13%
Mortality
12%
Chemotherapy
11%
Growth Hormone
10%
Somatomedin C
10%
Colon Cancer
9%
Diabetes Mellitus
9%
Cohort Study
8%
Anus Cancer
8%
Diseases
8%
Cancer Incidence
7%
Acromegaly
7%
Apoptosis
6%
Somatomedin
6%
Cell Death
6%
Insulin
5%
Carcinogenesis
5%
Breast Cancer
5%
Anticarcinogen
5%
Biochemistry, Genetics and Molecular Biology
Insulin-Like Growth Factor
25%
Body Mass
24%
Association
17%
Insulin-Like Growth Factor-Binding Protein
12%
Development
12%
Binding Protein
10%
Weight
10%
Survival
10%
Age
10%
Insulin Blood Level
9%
Colon
9%
Taxonomy
8%
Bevacizumab
8%
Health
7%
Smoking
7%
Cancer Incidence
6%
Artificial Neural Network
6%
Growth Hormone
6%
Screening
6%
Cell Death
6%
Mortality
6%
Insulin
5%
Peptide
5%
Adulthood
5%
Tumor Volume
5%
Phenotype
5%
Reduction (Chemistry)
5%
Cohort Study
5%
Sample
5%